Raymond James & Associates’s Viatris VTRS Stock Holding History

Raymond James & Associates’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,000	Closed	-$4.95K	–	4094
2022 Q4	$4.95K	Buy	+11,000	New	+$115K	﹤0.01%	3881
2022 Q3	–	Sell	-99,500	Closed	-$27K	–	4152
2022 Q2	$27K	Buy	99,500 +15,800	+19%	+$173K	﹤0.01%	3854
2022 Q1	$7K	Buy	83,700 +35,600	+74%	+$469K	﹤0.01%	4078
2021 Q4	$48K	Sell	48,100 -28,600	-37%	-$382K	﹤0.01%	3951
2021 Q3	$10K	Buy	76,700 +40,000	+109%	+$568K	﹤0.01%	4054
2021 Q2	$17K	Buy	36,700 +6,400	+21%	+$92.6K	﹤0.01%	3996
2021 Q1	$1K	Buy	+30,300	New	+$494K	﹤0.01%	3986
2018 Q1	–	Sell	-22,900	Closed	-$114K	–	3599
2017 Q4	$114K	Buy	+22,900	New	+$875K	﹤0.01%	3189
2017 Q3	–	Sell	-30,000	Closed	-$54K	–	3494
2017 Q2	$54K	Buy	+30,000	New	+$1.15M	﹤0.01%	3178

Other funds holding VTRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Raymond James & Associates's VTRS Position: Q3 2024 in Review

Raymond James & Associates increased its Viatris (VTRS) stake by 6% in Q3 2024, buying an estimated $917K and bringing the position to 1,406,036 shares worth $16.3M. The position accounts for 0.01% of the portfolio, ranked #931.

Raymond James & Associates first reported a position in VTRS in Q2 2013 and has held it in 46 quarters since. The position peaked at $26.9M in Q2 2017. 1,001 funds tracked by Wall St. Rank hold VTRS as of Q3 2024.

Raymond James & Associates held 1,406,036 shares of Viatris worth $16.3M as of Q3 2024.
Raymond James & Associates bought 79,494 Viatris shares in Q3 2024, an estimated $917K.
Viatris made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #931 holding.
Raymond James & Associates first reported a position in Viatris in Q2 2013 and has held it in 46 quarters since.
Raymond James & Associates's Viatris position peaked at $26.9M in Q2 2017.
1,001 funds tracked by Wall St. Rank held Viatris as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.